Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | -1.10% | -3.23% | -48.28% |
Jul. 05 | Sonnet BioTherapeutics Files Registration for Sale of Up to 5.77 Million Shares by Selling Stockholders | MT |
Jun. 20 | Top Midday Decliners | MT |
Chart calendar Sonnet BioTherapeutics Holdings, Inc.
Upcoming events on Sonnet BioTherapeutics Holdings, Inc.
Past events on Sonnet BioTherapeutics Holdings, Inc.
2024-05-14 | EF Hutton Investor Conference |
2024-05-14 04:15 pm | Q2 2024 Earnings Release |
2024-04-10 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 7181 |
2024-02-14 07:30 am | Q1 2024 Earnings Release |
2023-12-14 04:15 pm | Q4 2023 Earnings Release |
2023-11-02 01:30 pm | Connective Tissue Oncology Society Meeting - Abstract Number: 1566754 |
2023-08-31 | Reverse Split: 1 of 22 |
2023-08-31 09:00 am | Annual General Meeting |
2023-08-14 08:00 am | Q3 2023 Earnings Release |
2023-08-07 12:00 pm | BTIG Virtual Biotechnology Conference |
2023-06-29 02:40 pm | Cytokine-Based Drug Development Summit - Richard Kenney |
2023-06-27 01:00 pm | Cytokine-Based Drug Development Summit - John Cini |
2023-05-10 07:30 am | Q2 2023 Earnings Release |
2023-04-18 05:00 pm | American Association for Cancer Research Meeting |
2023-04-18 01:30 pm | American Association for Cancer Research Meeting - Abstract No: CT245 |
2023-02-13 08:00 am | Q1 2023 Earnings Release |
2022-11-02 08:30 am | Business Update Call |
2022-09-18 | Reverse Split: 1 of 14 |
2022-08-15 04:05 pm | Q3 2022 Earnings Release |
2022-06-23 09:00 am | Annual General Meeting |
Annual results
Fiscal Period | September | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,48 0,00 - | 0,35 0,40 -12.52% | 0,15 0,15 1.47% | 0,04 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -25,1 -24,7 -1.75% | 0,00 0,00 - | -18,8 -16,7 -12.42% | -13,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -25,0 -24,5 -2.05% | 0,00 0,00 - | -18,8 -16,7 -12.66% | -13,0 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -25,0 -24,5 -2.05% | 0,00 0,00 - | -18,8 -16,7 -12.78% | -13,0 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | -314 -320 1.92% | -150 -147 -2.4% | -18,1 -28,1 35.51% | -2,15 |
Announcement Date | 17/12/20 | 17/12/21 | 15/12/22 | 14/12/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,05 90.64% | 0,06 0,05 24.14% | 0,06 0,10 -37.25% | 0,04 0,10 -62.74% | 0,04 0,00 - | 0,04 0,00 - | 0,04 0,02 99.57% | 0,02 0,01 55.25% | 0,00 0,01 - | 0,02 | 0,02 |
EBIT Million USD | Released Forecast Spread | -8,21 -10,0 17.9% | -7,87 -9,00 12.59% | -3,60 -4,38 17.79% | -1,28 -3,64 64.84% | -3,87 -1,60 -141.11% | -3,88 | -3,98 | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,21 -10,0 17.92% | -7,88 -9,00 12.48% | -3,68 -4,38 16.04% | -1,17 -3,64 67.87% | 0,37 0,55 -33.92% | -3,88 | -3,98 | ||||
Net income Million USD | Released Forecast Spread | -8,21 -10,0 17.92% | -7,88 -9,00 12.48% | -3,68 -4,38 16.04% | -1,17 -3,64 67.87% | 0,37 0,55 -33.92% | -3,88 | -3,98 | ||||
EPS USD | Released Forecast Spread | -43,1 -40,0 -7.69% | -40,0 -43,1 7.14% | -37,2 -33,2 -11.92% | -17,6 -24,2 27.27% | -7,48 -10,9 31.31% | -2,86 -6,38 55.17% | -17,3 -4,09 -322.15% | -0,31 -0,86 63.95% | 0,07 -0,28 125.3% | -0,77 | -0,64 |
Announcement Date | 10/05/22 | 15/08/22 | 15/12/22 | 13/02/23 | 10/05/23 | 14/08/23 | 14/12/23 | 14/02/24 | 14/05/24 | - | - |
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Sonnet BioTherapeutics Holdings, Inc.
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SONN Stock
- Calendar Sonnet BioTherapeutics Holdings, Inc.